MedTrace Logo

Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis

NCT03268330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-01-12

No results posted yet for this study

Summary

Migration Inhibitory Factor has proliferative and antiapoptotic actions on fibroblasts which may be relevant to scleroderma because of the central role of a dysregulated fibroproliferative response in disease-affected tissues

Conditions

  • System; Sclerosis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Doaa K Mohamed, Lectruer · Assiut University

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2021-10-31
Completion
2021-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03268330 on ClinicalTrials.gov